Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Pneumonia, Pneumococcal 1Pneumococcal Infections 1Multiple Myeloma 1Febrile Neutropenia 1

Interventions

Meropenem 7Vancomycin 6pegfilgrastim 5Filgrastim 5Ceftazidime 5pegylated granulocyte colony-stimulating factor 4Cefepime 4Levofloxacin 3Ciprofloxacin 3Amikacin 3Teicoplanin 2Piperacillin, Tazobactam Drug Combination 2Linezolid 2Interleukin 1 Receptor Antagonist Protein 2Anti-Bacterial Agents 2Amoxicillin-Potassium Clavulanate Combination 2ceftolozane, tazobactam drug combination 1Vaccination 1Therapeutics 1Tazobactam 1TKN732 1Surveys and Questionnaires 1Sodium Chloride 1Simvastatin 1Positron Emission Tomography Computed Tomography 1Pneumococcal Vaccines 1Piperacillin 1Ofloxacin 1NF protocol 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Febrile Neutropenia × Pneumococcal Vaccines × Classical hematology × Clear all
NCT03619252 2022-08-31

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 4 Completed
36 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Pneumococcal Infections, Pneumonia, Pneumococcal, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡